Aug 5 First Friday Bioscience – How Concerts Novel DCE Platform Supercharges Drug Development and Compound Efficacy
Full Title: : How Concerts Novel DCE Platform® Supercharges Drug Development and Compound Efficacy
Speaker: Scott Harbeson, VP, Concert Pharamaceutical
Host: Medsupply Partners
Concert Pharmaceuticals is a clinical stage biotechnology company pioneering the use of deuterium in medicinal chemistry. Using their proprietary DCE Platform® (Deuterated Chemical Entity Platform) for replacement of specific hydrogen atoms with deuterium, approved drugs, advanced clinical candidates or previously studied compounds are transformed into new compounds that retain the pharmacological effectiveness of the validated drug molecules but, in select cases, improve metabolic profiles. Some compounds can be improved with deuterium substitution to provide better pharmacokinetic or metabolic properties and thereby enhance clinical safety, tolerability or efficacy.
Concert Pharmaceuticals has developed a robust pipeline of new medicines that offer improved ways to target a broad range of disease areas, including genetic diseases, autoimmune diseases, CNS disorders, inflammatory diseases, among others.
100 Cummings Center, Suite 221-E
Beverly MA USA
Date and Time
Begins: 08/05/2016 12:30 PM
Ends: 08/05/2016 02:00 PM
Speaker: Scott Harbeson
Scott Harbeson, Vice President, Concert Pharmaceuticals
Dr. Harbeson joined Concert in July 2006 and currently serves as Vice President, Drug Discovery and Basic Research. He has more than 25 years experience in medicinal chemistry in both venture-backed start-up and major pharmaceutical companies, including Ensemble Discovery, Vertex Pharmaceuticals, Alkermes, Marion Merrell Dow and Abbott Laboratories. He received his Ph.D. in Medicinal Chemistry at the University of Wisconsin-Madison from Professor Daniel H. Rich and was an NIH NRSA postdoctoral fellow with Professor Richard B. Silverman at Northwestern University
Registration, networking and lunch start at 12:30; Program
begins at 1 p.m.
MedSupply Partners has been providing quality laboratory equipment, consumables, scientific products and chemicals since 2003. Our managing partners bring over 25 years of industry experience to MedSupply Partners. Our experience and commitment to service has enabled us to become a trusted source for a wide variety of research products.
We are constantly striving for improvement. Please contact us if you have any suggestions as to how we can improve our lab supply business, products or service.
To learn more about MedSupply Partners, visit their website at www.medsupplypartners.com
See Who Has Registered:
To see who has registered for this event,
Online registration closes at 5 p.m. the day before this event. While walk-ins are never turned away, advance registration helps the team and is greatly appreciated.
Please note: The charge for All at the door registrations is $15.
Pizza, salad, and soft drinks will be served.
Add to my Outlook Calendar
Add to my iCal Calendar
Add to my Google Calendar
http://www.google.com/calendar/event?action=TEMPLATE&text=Aug 5 First Friday Bioscience – How Concerts Novel DCE Platform Supercharges Drug Development and Compound Efficacy&dates=20160805T163000Z/20160805T180000Z&sprop=null&details=Details: https://www.123signup.com/event?id=nxkms